4ZC9

Crystal Structure of the BRD4a/DB-2-190 complex

4ZC9 の概要

• エントリーDOI: 10.2210/pdb4zc9/pdb
• 分子名称: Bromodomain-containing protein 4, 2-[(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-N-(4-{[({2-[(3S)-2,6-dioxopiperidin-3-yl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}oxy)acetyl]amino}butyl)acetamide (3 entities in total)
• 機能のキーワード: bromodomain, small-molecule complex, signaling protein-inhibitor complex, signaling protein/inhibitor
• 由来する生物種: Homo sapiens (Human)
• 細胞内の位置: Nucleus: O60885
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 15884.65

構造登録者

Seo, H.-S.,DeAngelo, S.,Bradner, J.E. (登録日: 2015-04-15, 公開日: 2015-11-18, 最終更新日: 2024-03-06)

主引用文献

Winter, G.E.,Buckley, D.L.,Paulk, J.,Roberts, J.M.,Souza, A.,Dhe-Paganon, S.,Bradner, J.E.
DRUG DEVELOPMENT. Phthalimide conjugation as a strategy for in vivo target protein degradation.
Science, 348:1376-1381, 2015

PubMed Abstract: The development of effective pharmacological inhibitors of multidomain scaffold proteins, notably transcription factors, is a particularly challenging problem. In part, this is because many small-molecule antagonists disrupt the activity of only one domain in the target protein. We devised a chemical strategy that promotes ligand-dependent target protein degradation using as an example the transcriptional coactivator BRD4, a protein critical for cancer cell growth and survival. We appended a competitive antagonist of BET bromodomains to a phthalimide moiety to hijack the cereblon E3 ubiquitin ligase complex. The resultant compound, dBET1, induced highly selective cereblon-dependent BET protein degradation in vitro and in vivo and delayed leukemia progression in mice. A second series of probes resulted in selective degradation of the cytosolic protein FKBP12. This chemical strategy for controlling target protein stability may have implications for therapeutically targeting previously intractable proteins.

PubMed: 25999370
DOI: 10.1126/science.aab1433

実験手法

X-RAY DIFFRACTION (0.99 Å)